Cargando…
Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits
INTRODUCTION: Human placental protein 13 (PP13) is a galectin predominantly expressed by the placenta. Low serum concentrations of PP13 in early pregnancy indicate a higher risk of developing preeclampsia. METHODS: The pharmacokinetic disposition and bioavailability of PP13 were determined by single...
Autores principales: | Drobnjak, Tijana, Meiri, Hamutal, Mandalá, Maurizio, Huppertz, Berthold, Gizurarson, Sveinbjörn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037268/ https://www.ncbi.nlm.nih.gov/pubmed/30013317 http://dx.doi.org/10.2147/DDDT.S167926 |
Ejemplares similares
-
Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration
por: Drobnjak, Tijana, et al.
Publicado: (2019) -
Galectin 13 (PP13) Facilitates Remodeling and Structural Stabilization of Maternal Vessels during Pregnancy
por: Sammar, Marei, et al.
Publicado: (2019) -
Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function
por: Meiri, Hamutal, et al.
Publicado: (2017) -
The Role of the Carbohydrate Recognition Domain of Placental Protein 13 (PP13) in Pregnancy Evaluated with Recombinant PP13 and the DelT(221) PP13 Variant
por: Sammar, Marei, et al.
Publicado: (2014) -
Placental Protein 13 (PP13) – A Placental Immunoregulatory Galectin Protecting Pregnancy
por: Than, Nándor Gábor, et al.
Publicado: (2014)